Cargando…
Differential Cytotoxic Activity of a Novel Palladium-Based Compound on Prostate Cell Lines, Primary Prostate Epithelial Cells and Prostate Stem Cells
The outcome for patients with advanced metastatic and recurrent prostate cancer is still poor. Therefore, new chemotherapeutics are required, especially for killing cancer stem cells that are thought to be responsible for disease recurrence. In this study, we screened the effect of a novel palladium...
Autores principales: | Ulukaya, Engin, Frame, Fiona M., Cevatemre, Buse, Pellacani, Davide, Walker, Hannah, Mann, Vincent M., Simms, Matthew S., Stower, Michael J., Yilmaz, Veysel T., Maitland, Norman J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651166/ https://www.ncbi.nlm.nih.gov/pubmed/23675532 http://dx.doi.org/10.1371/journal.pone.0064278 |
Ejemplares similares
-
Phenotype-independent DNA methylation changes in prostate cancer
por: Pellacani, Davide, et al.
Publicado: (2018) -
HDAC inhibitor confers radiosensitivity to prostate stem-like cells
por: Frame, F M, et al.
Publicado: (2013) -
Overexpression of Placental Growth Factor in Stromal Cells from Benign Prostatic Hyperplasia: Another Piece in the Puzzle?
por: Devlin, Conor M., et al.
Publicado: (2020) -
Pyruvate Dehydrogenase Contributes to Drug Resistance of Lung Cancer Cells Through Epithelial Mesenchymal Transition
por: Cevatemre, Buse, et al.
Publicado: (2022) -
Cytotoxic Action of Palladium-Based Compound on Prostate Stem Cells, Primary Prostate Epithelial Cells, Prostate Epithelial Cells, and Prostate Cell Lines
por: Cheng, Long, et al.
Publicado: (2022)